Evidence map›Paper›PMID 19266325›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2009

Gene targeting in mouse embryonic stem cells.

Lino Tessarollo, Mary Ellen Palko, Keiko Akagi, Vincenzo Coppola

Open access · greenAbstract read
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Normal viability of Kai1/Cd82 deficient mice.Molecular carcinogenesis · 2014
    Article
  10. Article
  11. Article
  12. Tamalin is a critical mediator of electroconvulsive shock-induced adult neuroplasticity.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2012
    Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Lino TessarolloMouse Cancer Genetics Program, NCI-Frederick, Frederick, MD, USA.
Mary Ellen Palko
Keiko Akagi
Vincenzo Coppola
Cancer Genetics (United States) · US

Funding

Generation of Targeted Mutation in MiceZICBC010904 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI COPPOLA, VINCENZO · 2009 to 2009
$1.0M
Generation of Targeted Mutation in MiceZ01BC010904 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI COPPOLA, VINCENZO · 2008 to 2008
$451k
Intramural NIH HHS Z01 BC010904
6 · The paper itself

Abstract

The scientific value of a mouse model with a targeted mutation depends greatly upon how carefully the mutation has been engineered. Until recently, our ability to alter the mouse genome has been limited by both the lack of technologies to conditionally target a locus and by conventional cloning. The "cre/loxP" and "recombineering" technologies have overcome some of these limitations and have greatly enhanced our ability to manipulate the mouse genome in a sophisticated way. However, there are still some practical aspects that need to be considered to successfully target a specific genetic locus. Here, we describe the process to engineer a targeted mutation to generate a mouse model. We include a tutorial using the publicly available informatic tools that can be downloaded for processing the genetic information needed to generate a targeting vector.

Indexed as

Genetic VectorsAnimalsBase SequenceEmbryonic Stem CellsGene TargetingGenetic EngineeringMiceMice, KnockoutMolecular Sequence DataSequence Analysis, DNASequence Homology, Nucleic Acid

Identifiers

PMID19266325
PMCPMC7282145
OpenAlexW2411033364

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.